Market close: NZ shares edge ahead, F&P Healthcare rebounds
The S&P/NZX 50 Index edged ahead in a quiet end to the week.
AdvertisementAdvertise with NZME.
Latest fromCompanies
Air NZ Covid case: Was crew member infected during earlier Shanghai mission?
Airline doctor says infection first for Air NZ in 7.5 months, source may never be known.
Jarden Brief: TikTok owner running out of time to sell or face US ban
Jarden's daily update on the latest market moves and shakes.
Loyalty wars: Qantas swoops on flyers from other airline schemes
Switcheroo: Airline hoping to poach flyers from other loyalty schemes, including Air NZ.
Market close: NZ shares fall as Kiwi dollar weighs on market
The fast-rising NZ dollar began weighing on the New Zealand sharemarket.
Analysts ponder F&P Healthcare in a post-Covid world
F&P Healthcare's first-half profit leapt by 86 per cent, driven by Covid-19 demand.
Gentrack sinks deeper into red as Covid-19 bites
Software provider Gentrack has sunk deeper into the red over the September year.
Even in a pandemic, the billionaires are winning
New York Times: In the worst economic crisis since the 1930s, billionaires' wealth grew.
Jarden Brief: US market drops back down from record level
Jarden's daily update on the latest market moves and shakes.
Market close: Records order of the day, Mainfreight hits $61
The buoyant New Zealand sharemarket made another healthy gain on strong turnover.
Fletcher forecasts making $100m more in first six months
Fletcher to make nearly $100m more this year than last.
Jarden Brief: All eyes on Financial Stability report today
Jarden's daily update on the latest moves and shakes on the market.
Market close: F&P Healthcare surges, Harmoney slips further
The New Zealand sharemarket had another positive day.
Jarden Brief: Trump eyes restrictions on 89 Chinese companies
Jarden's daily update on the latest market moves and shakes.
Market close: Mainfreight's next stop, $62?
Energy stocks and other heavyweights made useful gains.
Metroglass reports flat first half, feels pressure of shipping delays
Metroglass reported a flat first half profit, supported by $6.1m in wage subsidies.
$3.3b listed landlord Goodman reports first-half $176.3m profit
Property valuations push down bottom-line result of industrial landlord.
Sylvia Park owner releases financial results, reveals Covid impact
$3.2b landlord's first-half result out.
Air NZ's Airpoints better earner than its airplanes - analysts
The estimated $725m value of Airpoints could be used as collateral in capital raise.
Cream of the crop? Fonterra's new chairman tells it like it is
Fonterra's new chairman "challenges everything".
A2 Milk plays up its Kiwi-ness as Chinese-Aussie ties sour
A2 Milk treads Kiwi line as relations between Australia and China grow ever more hostile.
What the pandemic cost Ryman Healthcare
Company bought four Alpaure AP4 sterilising fog machines for $1m - MacLeod.
Market close: NZX takes late dive, Ryman and F&P Healthcare fall
The New Zealand sharemarket fell nearly one per cent.
Jarden Brief: How Covid-19 surge is affecting US markets
Jarden's daily update on the latest market moves and shakes.
Ryman spends $50m on pandemic response
First half-year results out for NZ's biggest listed retirement business
Air NZ eyes new elite Airpoints tier, luxe seating
Surveys suggest sweeping changes to Airpoints and hint at look of biz class seats.
Market close: NZX falls for second straight day, Harmoney's slow start
The S&P/NZX 50 Index was down 0.39 per cent.
Harmoney fails to fire on ASX listing
Harmoney opted for a primary listing on the ASX, with a "foreign exempt" listing on NZX.
Jarden Brief: 65 US companies set to report earnings today
Jarden's daily update on the latest market moves and shakes.
Market close: Heavyweights drag NZX down
New Zealand sharemarket has its first drop in a fortnight.
Jarden Brief: Why Tesla shares leaped 8.2 per cent
Jarden's daily update on the latest market moves and shakes.
'Very surprising to us': Analyst on SkyCity executive exodus
Sudden departure of Graeme Stephens "very surprising to us" - Chelsea Leadbetter.
Market close: Vaccine news energises Covid-sensitive stocks
The New Zealand sharemarket had a slight gain.
Vaccine battle throws up market disclosure issues
Vaccine science has the power to shake the market. So what rules should govern disclosure?